Daphne Taylor - 02 Mar 2025 Form 4 Insider Report for Aptevo Therapeutics Inc. (APVO)

Role: SVP, CFO
Signature: /s/ SoYoung Kwon, Attorney-In-Fact
Issuer symbol: APVO
Transactions as of: 02 Mar 2025
Net transactions value: $0
Form type: 4
Filing time: 04 Mar 2025, 16:32:32 UTC
Previous filing: 09 Aug 2024
Next filing: 21 Jul 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APVO	Common Stock	Options Exercise		+2	+13%		17	02 Mar 2025	Direct	F1
transaction	APVO	Common Stock	Options Exercise		+1	+5.9%		18	04 Mar 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	APVO	Restricted Stock Unit	Options Exercise	$0	-2	-50%	$0.000000	2	02 Mar 2025	Common Stock	2		Direct	F1, F2
transaction	APVO	Restricted Stock Unit	Options Exercise	$0	-1	-100%	$0.000000	0	04 Mar 2025	Common Stock	1		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
F2	On March 3, 2023, the reporting person was granted 11,000 (7 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024.
F3	On June 7, 2022, the reporting person was granted 4,750 (3 post-splits) RSUs, vesting in three approximately equal annual installments beginning on March 4, 2023.